Use of ethinylestradiol/drospirenone combination in patients with the polycystic ovary syndrome

References

• ArmstrongVLWiggamMIInsulin action and insulin secretion in polycystic ovary syndrome treated with ethinyl oestradiol/cyproterone acetateQJM20019431711161134
   PubMed Web of Science ®Google Scholar
• AzzizRNestlerJEAndrogen excess disorders in women, polycystic ovary syndrome and other disorders20062Totowa, New JerseyHumana Press
   Google Scholar
• AzzizRWoodsKSThe prevalence and features of the polycystic ovary syndrome in an unselected populationJ Clin Endocrinol Metab2004892745915181052
   PubMed Web of Science ®Google Scholar
• BarthJHCherryCACyproterone acetate for severe hirsutism: results of a double-blind dose-ranging studyClinic Endocrinol(Oxf)199135510
   PubMed Web of Science ®Google Scholar
• BatukanCMuderrisIIEfficacy of a new oral contraceptive containing drospirenone and ethinyl estradiol in the long-term treatment of hirsutismFertil Steril2006854364016595223
   PubMed Web of Science ®Google Scholar
• CarlstromKKarlssonRDiurnal rhythm of and effects on oral contraceptives on serum dehydroepiandrosterone sulphate (DHEAS) are related to alterations in serum albumin rather than to changes in adrenocortical steroid secretionScand J Clini Lab Invest2002623618
   PubMed Web of Science ®Google Scholar
• CassidentiDLPaulsonRJEffects of sex steroids on skin 5 alpha-reductase activity in vitroObstetrics and Gynecology19917810371828548
   PubMed Web of Science ®Google Scholar
• CibulaDFantaMThe effect of combination therapy with metformin and combined oral contraceptives (COC) versus COC alone on insulin sensitivity, hyperandrogenaemia, SHBG and lipids in PCOS patientsHum Reprod200520180415576394
   PubMed Web of Science ®Google Scholar
• CibulaDSindelkaGInsulin sensitivity in non-obese women with polycystic ovary syndrome during treatment with oral contraceptives containing low-androgenic progestinHum Reprod200217768211756365
   PubMed Web of Science ®Google Scholar
• CreatsasGKoliopoulosCCombined oral contraceptive treatment of adolescent girls with polycystic ovary syndrome. Lipid profileAnn N Y Acad Sci20009002455210818412
   PubMed Web of Science ®Google Scholar
• DahlgrenELandinKEffects of two antiandrogen treatments on hirsutism and insulin sensitivity in women with polycystic ovary syndromeHum Reprod1998132706119804218
   PubMed Web of Science ®Google Scholar
• De LeoVMorganteGPiomboniPEvaluation of effects of an oral contraceptive containing ethinylestradiol combined with drospirenone on adrenal steroidogenesis in hyperandrogenic women with polycystic ovary syndromeFertil Steril200788113717418832
   PubMed Web of Science ®Google Scholar
• DingerJHeinemannLThe safety of a drospirenone containing oral contraceptive: final results from the European Active Surveillance study on oral contraceptives based on 142,475 women – years of observationContraception2007753445417434015
   PubMed Web of Science ®Google Scholar
• ElterKImirGClinical, endocrine and metabolic effects of metformin added to ethinyl estradiol-cyproterone acetate in non-obese women with polycystic ovarian syndrome: a randomized controlled studyHum Reprod20021717293712093831
   PubMed Web of Science ®Google Scholar
• Escobar-MorrealeHFLasuncionMATreatment of hirsutism with ethinyl estradiol-desogestrel contraceptive pills has beneficial effects on the lipid profile and improves insulin sensitivityFertil Steril200074816911020530
   PubMed Web of Science ®Google Scholar
• FalsettiLPasinettiEEffects of long-term administration of an oral contraceptive containing ethinylestradiol and cyproterone acetate on lipid metabolism in women with polycystic ovary syndromeActa Obstet Gynecol Scand19957456607856434
   PubMed Web of Science ®Google Scholar
• GuidoMRomualdiDDrospirenone for the treatment of hirsute women with polycystic ovary syndrome: a clinical, endocrinological, metabolic pilot studyJ Clin Endocrinol Metab20048928172315181063
   PubMed Web of Science ®Google Scholar
• HammersteinJMeckiesJUse of cyproterone acetate (CPA) in the treatment of acne, hirsutism and virilismJ Steroid Biochem1975682736126335
   PubMedGoogle Scholar
• KluftCEndrikatJA prospective study on the effects on hemostasis of two oral contraceptives containing drospirenone in combination with either 30 or 20 mcg ethinyl estradiol and a reference containing desogestrel and 30 mcg ethinyl estradiolContraception2006733364316531162
   PubMed Web of Science ®Google Scholar
• KnochenhauerESKeyTJPrevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective studyJ Clinic Endocrinol Metab199883307882
   PubMed Web of Science ®Google Scholar
• KorytkowskiMTMokanMMetabolic effects of oral contraceptives in women with polycystic ovary syndromeJ Clin Endocrinol Metab1995803327347593446
   PubMed Web of Science ®Google Scholar
• LavenJSEImaniBNew approach to polycystic ovary syndrome and other forms of anovulatory infertilityObstet Gynecol Surv2002577556712447098
   PubMed Web of Science ®Google Scholar
• LegroRSDriscollDEvidence for a genetic basis for hyperandrogenemia in polycystic ovary syndromeProc Natl Acad Sci USA19989514956609843997
   PubMed Web of Science ®Google Scholar
• LoboRAChoice of treatment for women with polycystic ovary syndromeFertil Steril200686Suppl 1S22316798280
   PubMed Web of Science ®Google Scholar
• MastorakosGKoliopoulosCAndrogen and lipid profiles in adolescents with polycystic ovary syndrome who were treated with two forms of combined oral contraceptivesFertil Steril2002779192712009344
   PubMed Web of Science ®Google Scholar
• Mauvais-JarvisPJayleMFIn vivo studies on metabolism of androgens following administration of steroid inhibitors of ovulation. 1. Changes in the secretion of androgens and excretion of their metabolites in normal subjects and women with the Stein-Leventhal syndromeActa Endocrinologica196550131445897059
   PubMedGoogle Scholar
• MichelmoreKFBalenAHPolycystic ovaries and associated clinical and biochemical features in young womenClin Endocrinol19995177986
   PubMed Web of Science ®Google Scholar
• MoghettiPTosiFComparison of spironolactone, flutamide, and finasteride efficacy in the treatment of hirsutism: a randomized, double blind, placebo-controlled trialJ Clin Endocrinol Metab200085899410634370
   PubMed Web of Science ®Google Scholar
• Morin-PapunenLVauhkonenIMetformin versus ethinyl estradiol-cyproterone acetate in the treatment of nonobese women with polycystic ovary syndrome: a randomized studyJ Clin Endocrinol Metab2003881485612519844
   PubMed Web of Science ®Google Scholar
• Morin-PapunenLCVauhkonenIEndocrine and metabolic effects of metformin versus ethinyl estradiol-cyproterone acetate in obese women with polycystic ovary syndrome: a randomized studyJ Clin Endocrinol Metab2000853161810999803
   PubMed Web of Science ®Google Scholar
• NaderSDiamanti-KandarakisEPolycystic ovary syndrome, oral contraceptives and metabolic issues: new perspectives and a unifying hypothesisHum Reprod2007223172217099212
   PubMed Web of Science ®Google Scholar
• NaderSRiad-GabrielMGThe effect of a desogestrel-containing oral contraceptive on glucose tolerance and leptin concentrations in hyperandrogenic womenJ Clin Endocrinol Metab199782307479284746
   PubMed Web of Science ®Google Scholar
• Palep-SinghMMookKAn observational study of Yasmin in the management of women with polycystic ovary syndromeJ Fam Plann Reprod Health Care200430163515222920
   PubMed Web of Science ®Google Scholar
• PehlivanovBMitkovMEfficacy of an oral contraceptive containing drospirenone in the treatment of women with polycystic ovary syndromeEur J Contracept Reprod Health Care20071230517455042
   PubMed Web of Science ®Google Scholar
• PugeatMNicolasMHAndrogens in polycystic ovarian syndromeAnn N Y Acad Sci1993687124358323167
   PubMed Web of Science ®Google Scholar
• van der VangeNBlankensteinMAEffects of seven low-dose combined oral contraceptives on sex hormone binding globulin, corticosteroid binding globulin, total and free testosteroneContraception199041345522139843
   PubMed Web of Science ®Google Scholar
• VenturoliSMarescalchiOA prospective randomized trial comparing low dose flutamide, finasteride, ketoconazole, and cyproterone acetate-estrogen regimens in the treatment of hirsutismJ Clin Endocrinol Metab19998413041010199771
   PubMed Web of Science ®Google Scholar
• VrbikovaJCibulaDCombined oral contraceptives in the treatment of polycystic ovary syndromeHum Reprod Update2005112779115790599
   PubMed Web of Science ®Google Scholar
• WiegratzIKutscheraEEffect of four different oral contraceptives on various sex hormones and serum-binding globulinsContraception200367253212521654
   PubMed Web of Science ®Google Scholar